Cite

    Qian Wu et al.. “Efficacy and safety of empagliflozin at different doses in patients with type 2 diabetes mellitus: A network meta‐analysis based on randomized controlled trials.” Journal of clinical pharmacy and therapeutics, vol. 47, 2022, pp. 270–286. http://access.bl.uk/ark:/81055/vdc_100152993260.0x000045